Yellow Fever

  • Requirements: Required if traveling from a country with risk of YFV transmission and ≥1 year of age. 1
  • Recommendations:
  • Recommended for all travelers ≥9 months of age, except as mentioned below.
  • Generally not recommended for travelers whose itinerary is limited to the following areas: the entire North Eastern Province; the states of Kilifi, Kwale, Lamu, Malindi, and Tanariver in the Coast Province; and the cities of Mombasa and Nairobi (see Map 3-30).


  • Areas with malaria: Present in all areas (including game parks) <2,500 m (8,202 ft) including the city of Nairobi (see Map 3-31).
  • Estimated relative risk of malaria for US travelers: Moderate.
  • Drug resistance 4: Chloroquine.
  • Malaria species: P. falciparum >85%, P. vivax 5%–10%, P. ovale up to 5%.
  • Recommended chemoprophylaxis: Atovaquone-proguanil, doxycycline, or mefloquine.
Map 3-30. Yellow fever vaccine recommendations in Kenya 1
Map 3-31. Malaria in Kenya


Brunette, Gary W., editor. "Kenya." CDC Yellow Book, Centers for Disease Control and Prevention, 2018. Relief Central,
Kenya. In: Brunette GW, ed. CDC Yellow Book. Centers for Disease Control and Prevention; 2018. Accessed March 25, 2019.
Kenya. (2018). In Brunette, G. W. (Ed.), CDC Yellow Book. Available from
Kenya [Internet]. In: Brunette GW, editors. CDC Yellow Book. Centers for Disease Control and Prevention; 2018. [cited 2019 March 25]. Available from:
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Kenya ID - 204310 ED - Brunette,Gary W, BT - CDC Yellow Book UR - PB - Centers for Disease Control and Prevention DB - Relief Central DP - Unbound Medicine ER -